View Post

Everything you need to know about CBC, the marijuana cannabinoid you never heard of

In Cannabinoids, Feature Stories by Katrina Eschner

The marijuana cannabinoid Cannabichromene (CBC) is a quiet presence in the scientific conversation about cannabis. But there’s a strong argument for understanding CBC better. The cannabinoid plays a major role in medical marijuana, and numerous clinical tests over the past 30 years suggest it has significant potential for treating illness. Except for newsmakers like THC or CBD, the cannabinoids that …

View Post

Canadian doctor studying the science behind marijuana strains

In Feature Stories, Research Topics by David Silverberg

A British Columbian doctor is investigating the compounds that make up marijuana in the hope of creating strains best suited for patients, a new report from MediJean outlines. Dr. Paul Hornby, a 62-year-old pathologist, has been studying cannabis for 15 years and in that time has profiled 15,000 different strains using high-pressure liquid chromatography (HPLC), an extremely sensitive analytical instrument. Over years …

View Post

Researchers reveal new way to determine THC levels in marijuana

In Research Topics, Top Stories by Dr. Tim Sandle, Ph.D.

Cannabis is a multifunctional plant that occupies a unique role in human culture. Some strains are used for hemp, which has a variety of uses; others are used to manufacture marijuana. One problem that has confounded scientists is how to tell different types of cannabis apart without destroying the plant. A research team based at the University of Frankfurt has …

View Post

Everything you need to know about THC

In Feature Stories, Research Topics by Katrina Eschner

Tetrahydrocannabidiol, or THC, is both the primary psychoactive component in cannabis and the “cannabinoid”—or medically active ingredient—that has historically made up the largest percentage of such compounds in most marijuana strains. As debates about the value of marijuana as medicine in North America have unfolded over the past decade and a half, we’ve all heard THC mentioned. Medical marijuana scientists …

View Post

How medical marijuana can help sick children

In Feature Stories by Matt DeLuca

Raising a child with a disease is a struggle for any parent, but when one California mother saw her autistic 9-year-old drop down to 42 pounds, she made a decision to try anything that might help him. Joey had been diagnosed with anorexia and malnutrition, conditions directly associated with the pharmaceuticals being used to treat his autism. Joey’s mother, Mieko …

View Post

Study: Exercise increases marijuana user’s THC levels

In Top Stories by David Silverberg

A new study, published in Drug and Alcohol Dependence, found that levels of THC were higher by an average of 15 percent immediately after marijuana users exercised. The study authors conclude: “These results suggest that exercise may elevate blood THC levels by releasing dormant THC from fat stores.” While THC levels were boosted in these exercisers, researchers didn’t study if intoxication increased after …

View Post

Parents, politicians pushing for sick kids be treated with medical marijuana

In Advocacy, Children, Feature Stories by Dr. Tim Sandle, Ph.D.

Medical marijuana and sick children may seem like an likely fit; however, the treatment has been recommended for nine-month-old Kaitlyn Pogson of Toronto. Physicians have suggested a cannabis oil extract may help alleviate the extreme seizures that have afflicted Kaitlyn since birth. Her parents are taking notice. In an exclusive interview with The Medical Marijuana Review, Kaitlyn’s father, Barry Pogson, …

View Post

Marijuana’s chemical compound THC can weaken most common strain of HIV virus

In Feature Stories, HIV, Research Updates and News by Chris Hogg

Preliminary research revealed THC can weaken HIV-1 infection, a new report published in the Journal of Leukocyte Biology explains. A synthetic version of THC, the main psychoactive ingredient in cannabis, was developed to attack the HIV-1 virus, which represents the vast majority (more than 90 percent) of all HIV types. Researchers found compounds that stimulate the cannabinoid type 2 (CB2) receptor in …